Recent ZYME News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2026 08:29:55 PM
- Zymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stock • GlobeNewswire Inc. • 05/14/2026 08:05:00 PM
- Zymeworks Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 05/13/2026 10:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 08:15:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 08:10:43 PM
- Zymeworks Provides Corporate Update and Reports First Quarter 2026 Financial Results • GlobeNewswire Inc. • 05/07/2026 08:05:00 PM
- Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/21/2026 09:30:00 PM
- Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform • GlobeNewswire Inc. • 04/17/2026 07:00:00 PM
- Zymeworks to Report First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026 • GlobeNewswire Inc. • 04/16/2026 10:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 08:10:04 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 08:05:08 PM
- Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth • GlobeNewswire Inc. • 04/09/2026 10:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/07/2026 06:24:31 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/07/2026 06:22:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2026 10:16:43 AM
- Zymeworks Appoints Kristin Stafford as Chief Financial Officer • GlobeNewswire Inc. • 04/01/2026 10:00:00 AM
- Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FRα-Targeting Antibody-Drug Conjugate • GlobeNewswire Inc. • 03/30/2026 10:00:00 AM
- Zymeworks Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 03/24/2026 10:00:00 AM
- Zymeworks Announces Presentations for Ziihera® (zanidatamab-hrii) at 2026 AACR Annual Meeting • GlobeNewswire Inc. • 03/18/2026 11:46:00 AM
- Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting • GlobeNewswire Inc. • 03/17/2026 09:02:34 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/07/2026 02:00:02 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/02/2026 12:23:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/02/2026 11:28:54 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 11:28:07 AM
- Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing • GlobeNewswire Inc. • 03/02/2026 11:10:00 AM

